United States · FDA National Drug Code directory
Zemdri (plazomicin)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80735-820_2b813678-540b-41e8-bed5-609cc99fd663
- Product NDC
- 80735-820
- Form
- INJECTION
- Composition / generic term
- Plazomicin
- Labeler
- Cipla Therapeutics Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180716
- Source listing expiry
- 20261231
Source-listed ingredients
- PLAZOMICIN — 500 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (80735-820-96) / 10 mL in 1 VIAL (80735-820-37) · 80735-820-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →